Fiche centre
UPMC Children's Hospital of Pittsburgh
Pittsburgh — United States
Essais liés9clinical trials
VillePittsburghlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07713706
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Emapalumab | Lupus | Phase 3 | NCT05001737 | EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE | COMPLETED |
| Galcanezumab | Migraine | Phase 3 | NCT04616326 | REBUILD-2 — A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine | ACTIVE_NOT_RECRUITING |
| Neural Mechanisms for Stopping Ongoing Speech Production (Study 2) | Épilepsie | Non applicable | NCT07713706 | Neural Mechanisms for Stopping Ongoing Speech Production (Study 2) | ENROLLING_BY_INVITATION |
| Constant Current Stimulator | Myopathies | Non applicable | NCT07715006 | Dorsal Root Electrical Stimulation in Children With Cerebral Palsy | RECRUITING |
| DYNE-251 | Myopathies | Phase 1/2 | NCT05524883 | DELIVER — Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping | ACTIVE_NOT_RECRUITING |
| EXCEL — A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition | Myopathies | À vérifier | NCT06581146 | EXCEL — A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition | RECRUITING |
| Galcanezumab | Migraine | Phase 3 | NCT03432286 | REBUILD-1 — A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine | ACTIVE_NOT_RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| Flexible Representation of Speech | Épilepsie | NA | NCT05209386 | Flexible Representation of Speech | COMPLETED |